You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 926 to 950 of about 5937
Next 25
06/05/2020
The McDowell Family Lost A Child To Cancer And Now They Are Creating a Tourist Attraction to Fund Research– So Why Are Some Of The Neighbors So Angry?
06/02/2020
Novocure Announces Launch of MyLink™ to Enable Patient-Guided, Remote Download of Optune® Usage Data
First Patient Treated in Phase 1 Clinical Trial Of Incysus Therapeutics Gamma Delta (?d) T Cell Immunotherapy for Patients With Newly Diagnosed Glioblastoma
Factors Affecting Survival in Glioblastoma: A 10-year Single-Center Experience From Saudi Arabia
06/01/2020
Phase 2a study to evaluate the safety, pharmacokinetics, and clinical activity of the PI3K / mTOR inhibitor GDC-0084 given to glioblastoma (GBM) patients with unmethylated MGMT promotor status
05/29/2020
ONC201 in previously irradiated pediatric H3 K27M-mutant glioma or newly diagnosed DIPG.
Al Musella`s ASCO Hightlights
Musella Foundation Awards Pediatric Brain Tumor Research Grant!
Musella Foundation Copay Assistance program is running low on funding
ASCO Brain Tumor Abstracts
Temozolomide Antagonizes Oncolytic Immunovirotherapy in Glioblastoma
Brain Tumor Webinars!
Al Musella`s ASCO Highlights Part 2
05/28/2020
A comprehensive survey reveals bacteria are widespread in human tumors and differ by tumor type
05/25/2020
Brain Tumor Awareness Webinars!
05/24/2020
Brain Tumor Webinar Series Continues tonight Sunday 5/24/2020 at 7PM Eastern
05/21/2020
No OS Boost With Opdivo in Recurrent Glioblastoma
Brain Tumor Webinar Series Continues
05/20/2020
Hoag is First in Nation to Test Innovative Antibody Brain Cancer Drug
05/19/2020
Novel Immunotherapy Approach Holds Promise for Pediatric Brain Cancer
05/17/2020
Musella Foundation Brain Tumor Awareness Month Webinar Series
05/15/2020
Brain Tumor Awareness Monthly Webinar Series video posted: Advances in neuro-imaging
Musella Foundation Webinar Series: A Promising New Radiotherapy for Recurrent Glioblastoma
05/13/2020
China NMPA Approves Optune® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
Plus Therapeutics Announces Patient-Focused Presentation Supporting Brain Tumor Awareness Month